Producing maternal health supplies in sub-Saharan Africa ...
Understanding the landscape to expand, strengthen, and diversify African-based manufacturing
In 2022, more than 8,000 people in the Kyrgyz Republic developed tuberculosis (TB), including
USP has launched the newest tool in our suite of solutions to address the evolving nitrosamines crisis: the Nitrosamines Analytical Hub, a public, web-based repository of downloadable analytical procedures to test for nitrosamine impurities and related substances in pharmaceuticals.
Manufacturing products locally for more equitable pandemic responses
How to secure upstream pharmaceutical supply chain risks with data and advanced technologies to increase access to quality medical products for patients